Evidence-Based Medicine Electronic Decision Support Study

Tampere University12,101 enrolled

Overview

The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care. Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group. Hypothesis (2) is that in the intervention group the quality measures will increase faster compared to the control group at follow-up time.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

DOUBLE

Enrollment

12,101

Conditions

Decision Support Systems, Clinical

Interventions

The EBMeDS remindersBEHAVIORAL

Phase I: EBMeDS reminders specific to the visiting or caring patient and his/her clinical problem are generated when the practitioner uses the electronic patient record. During visits of intervention group patients the EBMeDS reminders will be shown on screen to the practitioner. Phase II: As phase I and in addition, results of the Virtual Health Check (VHC) of all the intervention group patients will be shown to the practitioners.Phase II will be fulfilled in Autumn 2010 and follow-up time will be about 3 months.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All residents of Sipoo who have patient ID number in the Mediatri electronic patient record system in Sipoo Health Centre Exclusion Criteria: * Those residents who's occupational health care is produced by Sipoo Health Centre

Locations (1)

University of Tampere; School of Health Sciences

Tampere, Finland, Finland

Outcomes

Primary Outcomes

The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs)

VHC will be performed once a week for the whole study population, beginning at baseline and before randomisation. The main outcome measure is Ri/Ni at follow-up time after commencement of the study where Ri is the total number of reminders triggered by the patient record data in intervention and in control group at the time of analysis, and Ni is the total number of patients.

Time frame: Follow-up time max one and half year

Secondary Outcomes

Specific clinical measures compared to an intervention and a control group

Clinical measures as mean values of laboratory parameters, for example a mean level of HbA1c, a mean level of total cholesterol.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.